What are the side effects of garadacimab-ANDEMBRY?

Garadacimab (garadacimab)-ANDEMBRY has shown good safety and efficacy in clinical studies of angioedema, but there are still some side effects that need attention. In these studies, common adverse reactions with an incidence rate exceeding 7% mainly included nasopharyngitis and abdominal pain.

Nasopharyngitis is a relatively common upper respiratory tract infection that usually presents with symptoms such as nasal congestion, sore throat, and cough. For patients treated with Andembry, the occurrence of nasopharyngitis may be related to an immune system reaction. Although this reaction is usually mild, patients still need to pay close attention to their health when using this drug.

Abdominal pain is another common adverse reaction that may be related to the use of medications and usually manifests as abdominal discomfort, cramping, or bloating. Abdominal pain may have a variety of causes, including the effects of medications on the gastrointestinal tract, or may be related to the patient's underlying condition. In this situation, patients should communicate with their medical provider promptly to assess the severity of their symptoms and determine whether adjustments to their treatment plan are needed.

AlthoughAndembry has been shown to be well tolerated in clinical studies and most patients are able to manage these side effects well during treatment, it is still recommended that patients undergo regular health checkups while using the drug so that possible adverse reactions can be identified and dealt with early. In addition, patients should maintain communication with their doctors during use and promptly report any symptoms of discomfort to ensure the safety and effectiveness of treatment.

In general,Andembry, as an emerging treatment option, shows obvious advantages in preventing the onset of hereditary angioedema, but it is also necessary to pay attention to related side effects during use, such as nasopharyngitis and abdominal pain. With proper management and monitoring, patients can better enjoy the therapeutic benefits of this drug.

Reference materials:https://www.andembryhcp.com/